{"dataType": "CVE_RECORD", "dataVersion": "5.0", "cveMetadata": {"state": "PUBLISHED", "cveId": "CVE-2022-45611", "assignerOrgId": "8254265b-2729-46b6-b9e3-3dfca2d5bfca", "assignerShortName": "mitre", "dateUpdated": "2024-01-10T02:01:27.254275", "dateReserved": "2022-11-21T00:00:00", "datePublished": "2023-08-22T00:00:00"}, "containers": {"cna": {"providerMetadata": {"orgId": "8254265b-2729-46b6-b9e3-3dfca2d5bfca", "shortName": "mitre", "dateUpdated": "2024-01-10T02:01:27.254275"}, "descriptions": [{"lang": "en", "value": "An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information."}], "affected": [{"vendor": "n/a", "product": "n/a", "versions": [{"version": "n/a", "status": "affected"}]}], "references": [{"url": "https://www.fresenius-kabi.com/de-at/produkte/pharmahelp-compounder"}, {"url": "https://www.fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf"}, {"url": "https://www.fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf"}], "problemTypes": [{"descriptions": [{"type": "text", "lang": "en", "description": "n/a"}]}]}}}

{"configurations": [{"nodes": [{"cpeMatch": [{"criteria": "cpe:2.3:o:fresenius-kabi:pharmahelp_firmware:5.1.759.0:*:*:*:*:*:*:*", "matchCriteriaId": "D5E59598-8FC8-4D4D-833F-B21A7F2B55F8", "vulnerable": true}], "negate": false, "operator": "OR"}, {"cpeMatch": [{"criteria": "cpe:2.3:h:fresenius-kabi:pharmahelp:-:*:*:*:*:*:*:*", "matchCriteriaId": "D254891C-7278-4F2A-B422-AA874C3E16AC", "vulnerable": false}], "negate": false, "operator": "OR"}], "operator": "AND"}], "descriptions": [{"lang": "en", "value": "An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information."}], "id": "CVE-2022-45611", "lastModified": "2024-01-10T03:15:43.163", "metrics": {"cvssMetricV31": [{"cvssData": {"attackComplexity": "LOW", "attackVector": "NETWORK", "availabilityImpact": "HIGH", "baseScore": 9.8, "baseSeverity": "CRITICAL", "confidentialityImpact": "HIGH", "integrityImpact": "HIGH", "privilegesRequired": "NONE", "scope": "UNCHANGED", "userInteraction": "NONE", "vectorString": "CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H", "version": "3.1"}, "exploitabilityScore": 3.9, "impactScore": 5.9, "source": "nvd@nist.gov", "type": "Primary"}]}, "published": "2023-08-22T19:16:30.167", "references": [{"source": "cve@mitre.org", "tags": ["Product"], "url": "https://www.fresenius-kabi.com/de-at/produkte/pharmahelp-compounder"}, {"source": "cve@mitre.org", "url": "https://www.fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf"}, {"source": "cve@mitre.org", "url": "https://www.fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf"}], "sourceIdentifier": "cve@mitre.org", "vulnStatus": "Modified", "weaknesses": [{"description": [{"lang": "en", "value": "CWE-522"}], "source": "nvd@nist.gov", "type": "Primary"}]}

{}